Annotation Detail
Information
- Associated Genes
- INS
- Associated Variants
-
ENSG00000288674 p.Met239Val (p.M239V), PSEN2 p.Met239Val (p.M239V)
(
ENST00000366783.8,
ENST00000472139.2,
ENST00000679088.1,
ENST00000677599.1,
ENST00000676945.1,
ENST00000366782.6,
ENST00000626989.3,
ENST00000677880.1,
ENST00000677414.1,
ENST00000422240.6,
ENST00000678320.1 )
ENSG00000288674 p.Met239Val (p.M239V), PSEN2 p.Met239Val (p.M239V) ( ENST00000366782.6, ENST00000366783.8, ENST00000422240.6, ENST00000472139.2, ENST00000626989.3, ENST00000676945.1, ENST00000677414.1, ENST00000677599.1, ENST00000677880.1, ENST00000678320.1, ENST00000679088.1 ) - Associated Disease
- Impaired glucose tolerance
- Source Database
- DisGeNET
- Description
- Oral glucose tolerance tests on subjects with the presenilin 2 Met239Val mutation unaffected by early onset familial Alzheimer's disease (mean age 35 years) and on their first-degree relatives without the mutation demonstrated no evidence of glucose intolerance or increased proinsulin secretion.
- Pubmed
- 10362543
- Original source reporting the Gene Disease association
- BeFree
- DisGENET score for the Gene Disease association
- 0.167783701007798
- Year of publication
- 1999
Drugs